Global Alzheimer'S Platform Foundation

The GAP Foundation is joining together leading academic researchers, pharmaceutical companies, nonprofit organizations and foundations, and governments around the world to reduce the time, cost and risk of Alzheimer’s & Parkinson's clinical trials in order to speed innovative medicines to those with or at risk of Alzheimer’s & Parkinson's disease. GAP is a standing, global, trial-ready platform to drive quality, efficiency, equity and innovation in Alzheimer’s and Parkinson's Clinical Trials, seeking to reduce clinical testing cycle times by two years or more and to achieve greater trial populations. It is doing that by building large, well-characterized trial-ready cohorts, a network of certified high-performance clinical trial sites, and an adaptive proof-of-concept trial mechanism. Connect with us on our Facebook page, @GlobalALZPlatform, and on Twitter, @GAP_Foundation, where we share updates from our GAP-Network (GAP-Net) and from the volunteers that make it all possible.